e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Understanding the immunopathology that underlies airway obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
J. Onnipa (Bangkok, Thailand), T. Kawamatawong (Bangkok, Thailand), D. Pitidhammabhorn (Bangkok, Thailand), C. Setthaudom (Bangkok, Thailand)
Source:
International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Session:
Understanding the immunopathology that underlies airway obstructive diseases
Session type:
Poster Discussion
Number:
5000
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Onnipa (Bangkok, Thailand), T. Kawamatawong (Bangkok, Thailand), D. Pitidhammabhorn (Bangkok, Thailand), C. Setthaudom (Bangkok, Thailand). Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction. 5000
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Parameters associated with persistent airflow obstruction in chronic severe asthma
Source: Eur Respir J 2004; 24: 122-128
Year: 2004
Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002
Eicosanoids and eosinophilic inflammation of airways in stable COPD.
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Airway pathology in asthma
Source: Eur Respir J 2001; 18: 18S-23S
Year: 2001
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
The role of small airways in obstructive airway diseases
Source: Eur Respir Rev 2011; 20: 23-33
Year: 2011
Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Small airways disease in asthma with-and without- fixed airflow obstruction and COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Proximal and peripheral airway morphologic changes in elderly patients with asthma with fixed airflow obstruction and COPD
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Source: Eur Respir J 2012; 40: 1098-1105
Year: 2012
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006
Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008
The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005
The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Source: Eur Respir J 2007; 29: 906-913
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept